University of Cincinnati Cancer Center CTO — Cincinnati, Ohio

University of Cincinnati Cancer Center CTO is a clinical research site located in Cincinnati, Ohio, United States 45267.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

University of Cincinnati Cancer Center CTO has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.

Sponsors: Sirtex Medical.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Cincinnati Cancer Center CTO?

University of Cincinnati Cancer Center CTO has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Cincinnati Cancer Center CTO conducted?

University of Cincinnati Cancer Center CTO has 1 clinical trials on record, with 1 currently active. Their work covers Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma.

Is University of Cincinnati Cancer Center CTO accredited by Crixeo Health?

University of Cincinnati Cancer Center CTO has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Cincinnati Cancer Center CTO?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.